Skip to main content
. 2014 Jan 17;3:e27572. doi: 10.4161/onci.27572

graphic file with name onci-3-e27572-g1.jpg

Figure 1. Diagnosis and previous treatments of patients enrolled in clinical trials testing γδ T cell-based immunotherapy. AML, acute myeloid leukemia; CA, carcinoma; CLL, chronic lymphocytic leukemia; NSCLC, non-small cell lung carcinoma; PBMC, peripheral blood mononuclear cell; PBSCT, peripheral blood stem cell transplantation; RCC, renal cell carcinoma.